APA (7th ed.) Citation

HM, A., IA, A., MAA, F., Y, M., A, M., MF, E., . . . KAM, A. (2021). Lipid polymer hybrid nanocarriers as a combinatory platform for different anti-SARS-CoV-2 drugs supported by computational studies. RSC advances, 11(46), 28876. https://doi.org/10.1039/d1ra04576h

Chicago Style (17th ed.) Citation

HM, Abdel-Bar, Abdallah IA, Fayed MAA, Moatasim Y, Mostafa A, El-Behairy MF, Elimam H, Elshaier YAMM, and Abouzid KAM. "Lipid Polymer Hybrid Nanocarriers as a Combinatory Platform for Different Anti-SARS-CoV-2 Drugs Supported by Computational Studies." RSC Advances 11, no. 46 (2021): 28876. https://doi.org/10.1039/d1ra04576h.

MLA (9th ed.) Citation

HM, Abdel-Bar, et al. "Lipid Polymer Hybrid Nanocarriers as a Combinatory Platform for Different Anti-SARS-CoV-2 Drugs Supported by Computational Studies." RSC Advances, vol. 11, no. 46, 2021, p. 28876, https://doi.org/10.1039/d1ra04576h.